Allergy and Immunology · Paducah, KY
NPI
1598021438
Since 2012
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2312 Kentucky Ave
Paducah, KY, 42003
Phone (800) 999-1249
Groups this clinician bills Medicare through
Medicare paid, 2024
$483K
29,239 services
Medicare patients, 2024
310
Average age 72
Drug cost, 2024
$345K
1,619 prescriptions
Company payments, 2025
$2,909
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie A Davenport was code J2356 (injection, tezepelumab-ekko, 1 mg), 17,642 times for 14 patients. In total Julie A Davenport billed 29,239 services in 27 codes, and Medicare paid $483K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 17,642 | 14 | $14.26 | $252K |
| 95004 Test - Miscellaneous | Office | 3,383 | 53 | $2.53 | $8,547 |
| 95165 Treatment - Miscellaneous | Office | 1,170 | 58 | $10.03 | $12K |
| 95117 Treatment - Miscellaneous | Office | 674 | 59 | $7.98 | $5,381 |
| 99213 Office E&M - Established | Office | 272 | 209 | $55.45 | $15K |
| 96372 Injection Administration | Office | 200 | 33 | $10.22 | $2,045 |
| 95024 Test - Miscellaneous | Office | 165 | 16 | $5.52 | $910 |
| 96160 E&M - Miscellaneous | Office | 121 | 98 | $1.75 | $212 |
| 94375 Pulmonary Function Testing | Office | 66 | 61 | $23.43 | $1,546 |
| 99204 Office E&M - New | Office | 53 | 53 | $115.11 | $6,101 |
| 95012 Pulmonary | Office | 50 | 47 | $12.50 | $625 |
| 94060 Pulmonary Function Testing | Office | 43 | 40 | $26.18 | $1,126 |
| 94664 E&M - Miscellaneous | Office | 37 | 37 | $12.23 | $453 |
| 99203 Office E&M - New | Office | 22 | 22 | $68.81 | $1,514 |
By year: 2022 $21K for 936 services; 2023 $234K for 16,473 services; 2024 $483K for 29,239 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie A Davenport prescribed most often to Medicare patients was Fluticasone Propionate, with 241 prescriptions and refills. In total Julie A Davenport wrote 1,619 Medicare prescriptions that cost $345K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 241 | 415 | 116 | $2,731 |
| Azelastine Hcl Generic | 219 | 383 | 107 | $7,381 |
| Montelukast Sodium Generic | 218 | 426 | 70 | $1,831 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 118 | 134 | 31 | $83K |
| Symbicort Budesonide/Formoterol Fumarate | 90 | 118 | 35 | $26K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 74 | 84 | 43 | $1,844 |
| Famotidine Generic | 68 | 99 | 14 | $449 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 62 | 87 | 23 | $10K |
| Epinephrine Generic | 60 | 64 | 49 | $12K |
| Levocetirizine Dihydrochloride Generic | 49 | 101 | 15 | $558 |
| Airsupra Albuterol Sulfate/Budesonide | 41 | 41 | 20 | $23K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 37 | 47 | 12 | $5,747 |
| Breyna Budesonide/Formoterol Fumarate | 34 | 46 | Under 11 | $5,593 |
| Breo Ellipta Fluticasone/Vilanterol | 32 | 44 | Under 11 | $17K |
| Ipratropium Bromide Generic | 28 | 46 | 12 | $799 |
Brand drugs: 579 claims; generic drugs: 1,040 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie A Davenport $2,909 ($2,909 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $811.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 28 | $811 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $542 |
| GlaxoSmithKline, LLC. GSK | 18 | $319 |
| Amgen Inc. AMGN | 12 | $272 |
| CSL Behring CSL.AX | 11 | $266 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 20 | $255 |
| Genzyme Corporation SNY | 5 | $93.52 |
| Cycle Pharmaceuticals Inc | 3 | $75.97 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $61.14 |
| Genentech USA, Inc. ROG.SW | 2 | $52.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.